Development and Analytical Validation of a Targeted Next-Generation Sequencing Panel to Detect Actionable Mutations for Targeted Therapy

BACKGROUND: The ability to rapidly, inexpensively, and accurately identify cancer patients based on actionable genomic mutations in tumour specimens is becoming critically important in routine clinical diagnostics. Targeted panel sequencing is becoming popular because it enables comprehensive and co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dandan, Ma, Kai, Deng, Wei, Li, Jingyu, Xiang, Shaohua, Zhang, Yang, Fu, Ying, Dai, Heng, Huang, Bingding
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039190/
https://www.ncbi.nlm.nih.gov/pubmed/33854338
http://dx.doi.org/10.2147/OTT.S299381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039190/
https://www.ncbi.nlm.nih.gov/pubmed/33854338
http://dx.doi.org/10.2147/OTT.S299381

Ejemplares similares